H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. is a federal contractor, registered under UEI DVHKP4N619V9 and CAGE code 1X4B9. It has been awarded $1,060,685,700 in federal contracts. Primary work spans Unknown NAICS, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology), and Other NAICS codes (14 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Department Of Health And Human Services (hhs).
Contact Information
Registration and classification details
Registration
UEI Code
DVHKP4N619V9CAGE Code
1X4B9Entity Structure
Corporate Entity (Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. specializes in advanced cellular therapy manufacturing, process development, and life sciences research support for federal health agencies. Their core capabilities include the isolation, expansion, and cryopreservation of specialize...
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. specializes in advanced cellular therapy manufacturing, process development, and life sciences research support for federal health agencies. Their core capabilities include the isolation, expansion, and cryopreservation of specialized immune cell populations—such as T-regulatory cells and CD4+ CM T cells—for clinical applications, alongside the operation of GMP-compliant cell processing facilities. They provide end-to-end manufacturing services for investigational cellular products, including process optimization, analytical characterization, and biorepository management for complex immunotherapies. Their technical expertise spans cell culture systems, automated bioprocessing, cryogenic storage protocols, and biomaterial handling for cell-based therapeutics, with demonstrated experience supporting National Institutes of Health initiatives in myelodysplastic syndromes and cellular immunotherapy development. The organization maintains a sustained relationship with the Department of Health and Human Services, delivering research and development services for national natural history studies, central laboratory operations, and biorepository infrastructure. They also support the Department of Veterans Affairs with specialized pathology consultation services, indicating capacity for clinical diagnostics aligned with translational research. Their primary focus is in NAICS 541712, where they operate at the intersection of academic research and federal biomanufacturing, bridging laboratory innovation with scalable, regulated cell production. This positions them as a niche provider of non-biotech cellular therapy development services within the federal life sciences ecosystem. As a non-certified academic medical research entity based in Tampa, Florida, they function as a mission-driven research hospital leveraging institutional infrastructure to deliver high-complexity federal contracts. Their geographic presence is centered in Florida, with federal market positioning rooted in deep scientific expertise rather than commercial certifications.
Key Performance Metrics
Awards Count
1,021
All time
Active
126
Currently performing
Completed
895
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
